Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
J Dent Res ; 94(3 Suppl): 52S-58S, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25406168

ABSTRACT

Several epidemiologic studies have suggested that oral disease is a risk factor for cardiovascular disease (CVD). However, whether a clinically significant association exists between the 2 disorders remains controversial. Here, we investigated the association between tooth loss, as an indicator of oral disease, and arterial stiffness, as a marker of atherosclerosis, in Japanese adults. Cross-sectional data were collected for 8,124 persons aged 30 to 75 y with no history of tooth loss for noninflammatory reasons, such as orthodontic treatment, malposition, and trauma. Participants received a comprehensive dental examination and extensive in-person measurements of CVD risk factors, and arterial stiffness was evaluated using the cardio-ankle vascular index (CAVI). We examined the association between CAVI and tooth loss using general linear models with adjustment for age, sex, body mass index, smoking status, hemoglobin A1c, and a history of insulin or hypoglycemic medication depending on the model. In addition, we performed an analysis that included interaction terms of the centered variables tooth loss, sex, and age. The results of the multiple regression analysis that included the interaction terms detected that the relationship between CAVI and tooth loss was dependent on sex, with only men showing a positive correlation (ß for interaction = 0.04; 95% confidence interval, 0.02-0.06). The findings from this study suggest that a linear relationship exists between tooth loss and degree of arterial stiffness and that the association differed depending on sex.


Subject(s)
Atherosclerosis/epidemiology , Tooth Loss/epidemiology , Adult , Age Factors , Aged , Aged, 80 and over , Body Mass Index , Cohort Studies , Comprehensive Dental Care , Cross-Sectional Studies , Female , Glycated Hemoglobin/analysis , Humans , Hypoglycemic Agents/therapeutic use , Insulin/therapeutic use , Japan/epidemiology , Linear Models , Male , Middle Aged , Population Surveillance , Prospective Studies , Risk Factors , Sex Factors , Smoking/epidemiology , Vascular Stiffness/physiology
2.
Int J Oral Maxillofac Surg ; 41(11): 1397-403, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22840716

ABSTRACT

This study estimated the cumulative incidence and risk ratio for osteonecrosis of the jaw (ONJ) after tooth extraction in patients with and without administration of bisphosphonates (BP) and identified potential risk factors for bisphosphonate-induced osteonecrosis of the jaw (BIONJ). A cohort study was conducted in all patients undergoing tooth extraction at a university hospital in Japan from April 2006 to June 2009. Of 3216 patients, 126 had BP administration, of whom 5 (3.9%, 95% confidence interval (CI): 1.2-9.2) developed ONJ, versus 1 (0.032%, 95% CI: 0.00081-0.18) among 3090 patients without BP administration. BP administration was associated with the development of ONJ after tooth extraction, with an unadjusted risk ratio of 122.6 (95% CI: 14.4-1041.8). When stratified by age and route of BP administration, the risk ratio for ONJ patients aged 65 years or older with intravenous BP administration compared to those without was 200.2 (95% CI: 23.8-1679.4, P<0.001). Patients receiving BP showed a significant association between the incidence of BIONJ and alveolar bone loss score. The risk of ONJ is higher in patients with than without BP administration, particularly intravenous administration. Severe periodontitis might be a risk factor for BIONJ.


Subject(s)
Bisphosphonate-Associated Osteonecrosis of the Jaw/epidemiology , Tooth Extraction/adverse effects , Adult , Aged , Aged, 80 and over , Cohort Studies , Female , Humans , Incidence , Male , Middle Aged
3.
East Afr Med J ; 79(2): 58-64, 2002 Feb.
Article in English | MEDLINE | ID: mdl-12380877

ABSTRACT

OBJECTIVE: To examine the relationship between obesity and lipid profiles and to compare the effects of total obesity and central adiposity on lipids in three locations in Tanzania. DESIGN: Cross-sectional epidemiological study. SETTING: Three areas in Tanzania: Dar es Salaam (urban), Handeni (rural) and Monduli (pastoralists), in August 1998. SUBJECTS: Five hundred and forty five men and women from a random sample of 600 people aged 46-58 years. MAIN OUTCOME MEASURES: Mean BMI, waist circumference, WHR, TC, HDL-C, LDL-C, TG and LDL/HDL ratio. Prevalence rates of overweight,obesity, central obesity and dyslipidaemia. RESULTS: As compared to men, women had higher BMI (24.7 versus 22.5 kg/m2, p<0.0001), waist circumference (92.4 versus 89.1 cm, p<0.05), TC (4.9 versus 4.2 mmol/L, p<0.0001) and LDL-C (3.3 versus 2.6 mmol/L, p<0.0001). The urban population demonstrated higher levels of lipid factors than the rural population (TC, men 4.8 mmol/L; women 5.3 mmol/L, p<0.0001; TG, men 3.6 mmol/L; women 3.7 mmol/L, p<0.0001, LDL-C, men 2.8 mmol/L, p<0.0001). BMI and waist circumference correlated positively with serum TC, TG, and LDL-C in both genders. Stepwise regression analysis showed that BMI predicted triglyceride concentration in men (p<0.05) and women (p<0.0001). Waist circumference predicted levels of TC in women only (p<0.0001) and of LDL-C in both genders (men p<0.05, women p<0.0001). The prevalence of overweight, obesity and central obesity were significantly higher in urban than in rural areas in both men and women. Compared to lean subjects, obese men and women had significantly higher mean serum TC, TG, LDL-C and a higher prevalence of dyslipidaemia. The mean levels of TC, TG and LDL cholesterol increased across successive increases in BMI and waist circumference quintiles in both genders. CONCLUSION: Subjects from the urban area had greater lipid abnormalities related to obesity than those from the rural area and that, central adiposity had a greater effect on total cholesterol and LDL cholesterol among women than was BMI.


Subject(s)
Lipoproteins/blood , Obesity/epidemiology , Body Mass Index , Body Weights and Measures , Cholesterol/blood , Cross-Sectional Studies , Diet, Reducing , Female , Humans , Male , Middle Aged , Obesity/blood , Obesity/diagnosis , Rural Population , Tanzania/epidemiology , Triglycerides/blood , Urban Population
4.
Int Immunol ; 13(12): 1561-70, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11717197

ABSTRACT

Although some animal models suggest an involvement of CD4 T cells reactive to luminal microbial antigen(s) for the pathogenesis of inflammatory bowel diseases (IBD), direct linkage between microflora-driven clonal expansion of CD4 T cells and the development of colitis has not been well studied. Here, BALB/c and SCID mice were given CD4 T cells purified from Rag-2(-/-) mice crossed to transgenic mice expressing TCR specific to ovalbumin (OVA) then administered with antibiotic-resistant Escherichia coli producing OVA (ECOVA) or LacZ (ECLacZ) via the rectum. The ECOVA-inoculated BALB/c and SCID mice developed a subacute colitis with microscopic features of distortion of crypt architecture, loss of goblet cells, and focal infiltration by mononuclear cells in the lamina propria (LP) and submucosa. Expanding OVA-specific CD4 T cells were detected in colonic follicles of mice with ECOVA. Early in colitis, OVA-specific CD4 T cells producing IFN-gamma predominate in the LP of the colon, which was followed by an emergence of OVA-specific CD4 T cells producing IL-4 and IL-10 at a later time point. Co-transfer of an IL-10-secreting OVA-specific CD4 T cell line prevented colitis. Thus, an expansion of CD4 T cells monospecific to OVA, an antigen non-cross-reactive to colonic tissue, can mediate both induction and inhibition of the colitis which was associated with hyperplasia of lymph follicles.


Subject(s)
Adoptive Transfer , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/transplantation , Colitis/immunology , Epitopes, T-Lymphocyte/immunology , Escherichia coli/immunology , Ovalbumin/immunology , Administration, Rectal , Adoptive Transfer/methods , Animals , Antigens, Bacterial/administration & dosage , Antigens, Bacterial/biosynthesis , Antigens, Bacterial/genetics , CD4-Positive T-Lymphocytes/metabolism , Cell Line , Colitis/pathology , Colitis/prevention & control , Colon/pathology , Cytokines/biosynthesis , Disease Models, Animal , Epitopes, T-Lymphocyte/administration & dosage , Epitopes, T-Lymphocyte/genetics , Escherichia coli/genetics , Injections, Intravenous , Interleukin-10/biosynthesis , Intestinal Mucosa/immunology , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Lac Operon/immunology , Mice , Mice, Inbred BALB C , Mice, Knockout , Mice, SCID , Mice, Transgenic , Ovalbumin/administration & dosage , Ovalbumin/biosynthesis , Ovalbumin/genetics , Plasmids/administration & dosage , Plasmids/biosynthesis , Plasmids/immunology , Wasting Syndrome/immunology
5.
Acta Trop ; 79(3): 231-9, 2001 Jun 22.
Article in English | MEDLINE | ID: mdl-11412807

ABSTRACT

In this assessment of cardiovascular risk factors, we examined the prevalence of selected risk factors according to the World Health Organisation (WHO) CARDIAC Study protocol and compared them with a similar study conducted more than a decade ago. The survey was carried out in Dar es Salaam (D, urban), Handeni (H, rural) and Monduli (Mo, semi-nomadic area). Subjects aged 47-57 were recruited randomly for blood pressure and anthropometrical measurements, 24 h urine collection and blood sampling. A structured questionnaire was used to obtain dietary information. The 1998 survey studied 446 subjects, while the 1987 survey included 496 men and women. The measured weight, body mass index (BMI) and prevalence of obesity (BMI > or = 30 kg/m(2)) increased significantly among women in the 1998 survey in rural Handeni and urban Dar. The overall prevalence of obesity was higher for women in the most recent survey (22.8%, P < 0.0001). Diastolic blood pressure (DBP) was higher in the most recent survey for women in Handeni. The overall prevalence of hypertension (blood pressure > 160/95 mmHg, or antihypertensive drug use), rose to 41.1% in 1998, (P < 0.001) for men and to 38.7% (P < 0.05) for women. The mean total serum cholesterol and prevalence of hypercholesterolaemia increased significantly in the most recent survey in the three studied areas. The overall prevalence of hypercholestrolaemia (serum cholesterol > 5.2 mmol/l) was higher in the 1998 survey for both men (21.8%, P < 0.0001) and women (54.0%, P < 0.0001). The mean HDL cholesterol increased significantly in the most recent survey, with a significant reduction in the mean atherogenic index, though these were still at higher levels (men 5.8, P < 0.0001; women 5.1, P < 0.0001 vs. 1987). A strong positive correlation was observed between blood pressure (SBP and DBP) and body mass index, total serum cholesterol and sodium to potassium ratio. These data suggest that for the past decade there has been an increase in the mean levels and prevalence of selected cardiovascular risk factors in Tanzania.


Subject(s)
Cardiovascular Diseases/epidemiology , Blood Pressure , Body Weight , Cardiovascular Diseases/blood , Cardiovascular Diseases/etiology , Cardiovascular Diseases/urine , Cholesterol/blood , Cholesterol, HDL/blood , Diet , Female , Humans , Hypercholesterolemia/epidemiology , Hypertension/epidemiology , Male , Middle Aged , Obesity/epidemiology , Potassium/urine , Prevalence , Risk Factors , Sodium/urine , Surveys and Questionnaires , Tanzania/epidemiology
6.
Chemotherapy ; 44(3): 181-9, 1998.
Article in English | MEDLINE | ID: mdl-9612608

ABSTRACT

The changes of pharmacokinetic parameters when levofloxacin (LVFX) and vancomycin (VCM) were administered concomitantly were studied in rats. There was an increase in the AUC and Tmax of LVFX with concomitant administration, but no effect on Cmax. There was also an increase in the AUC and T1/2 of VCM with concomitant administration, while Vd was reduced. Concomitant administration had no effect on the correlation between the serum and hepatic tissue concentrations of LVFX, but it markedly decreased the correlation between the serum and renal tissue concentrations of VCM. BUN was increased at 8 h after the administration of VCM. There have been reports that renal dysfunction can be caused by VCM, and our findings suggested that concomitant administration of LVFX and VCM must be performed with caution.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Anti-Infective Agents/pharmacokinetics , Levofloxacin , Ofloxacin/pharmacokinetics , Vancomycin/pharmacokinetics , Animals , Anti-Bacterial Agents/blood , Anti-Infective Agents/blood , Drug Interactions , Kidney/drug effects , Liver/drug effects , Male , Ofloxacin/blood , Rats , Rats, Wistar , Vancomycin/blood
7.
Bone Marrow Transplant ; 20(4): 337-40, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9285550

ABSTRACT

A patient with AML (FAB M4Eo) developed EBV-LPD 1.5 months after allogeneic BMT from his one locus-mismatched mother, the diagnosis being confirmed on day +82. Attempts to eradicate the monoclonally proliferating LPD using chemotherapy (VP16/dexamethasone) followed by two doses of EBV-specific CTL and one dose of unstimulated donor leukocytes were not successful. We assume delay of infusions (day +100, +107) and insufficient CTL cell doses (total 9.2 x 10(6)) may have been responsible for the poor outcome in this case.


Subject(s)
Bone Marrow Transplantation/adverse effects , Herpesviridae Infections/therapy , Herpesvirus 4, Human , Lymphoproliferative Disorders/therapy , T-Lymphocytes, Cytotoxic/transplantation , Tumor Virus Infections/therapy , Child , Herpesviridae Infections/etiology , Humans , Lymphoproliferative Disorders/etiology , Male , Transplantation, Homologous , Tumor Virus Infections/etiology
9.
Br J Radiol ; 70(837): 964-6, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9486078

ABSTRACT

Horseshoe lung is a rare pulmonary anomaly characterized by fusion of the posterobasal portions of the right and left lungs behind the pericardial reflection, anterior to the aorta. The majority of reported cases occur in conjunction with scimitar syndrome, including hypoplasia of the right lung, anomalous right pulmonary venous return and systemic arterial supply to the lung. Horseshoe lung is usually diagnosed on pulmonary arteriography when the right inferior pulmonary artery crosses the midline and extends to the left lung base. Bronchography is also diagnostic when the branch of horseshoe portion arises from the right bronchus and passes within the lung parenchyma to midline of the lung tissue. The only described CT finding of horseshoe lung is the contiguity of the right and left lungs behind the heart. Most cases are infants under 12 months of age and CT images are severely hampered by respiration motion artefacts. Such artefacts are minimized by using electron-beam computed tomography, allowing a more detailed CT appearance of horseshoe lung in this case.


Subject(s)
Lung/abnormalities , Tomography, X-Ray Computed/methods , Child, Preschool , Electrons , Female , Humans , Lung/diagnostic imaging
10.
Acta Med Okayama ; 48(2): 113-5, 1994 Apr.
Article in English | MEDLINE | ID: mdl-8042535

ABSTRACT

Effects of acute (15h) and chronic (15h x 7 days) immobilization (IM) stress on plasma levels of nicorandil [N-(2-hydroxyethyl) nicotinamide nitrate (ester)] administered orally were examined in rats. The maximum plasma level was reached 30 min after administration. Acute IM stress significantly reduced plasma nicorandil levels both in the absorption and elimination phases (15 min and 2-6h after administration, respectively). Chronic IM stress further intensified the reduction of nicorandil levels in the absorption phase, but attenuated the influence of acute stress in the elimination phase. No significant difference was observed one day after removal of chronic IM stress. These results suggest that chronic IM stress markedly inhibits the absorption of nicorandil, but the distribution, metabolism and excretion were influenced more by acute IM stress.


Subject(s)
Niacinamide/analogs & derivatives , Stress, Psychological/metabolism , Acute Disease , Administration, Oral , Animals , Chronic Disease , Intestinal Absorption , Male , Niacinamide/administration & dosage , Niacinamide/blood , Niacinamide/pharmacokinetics , Nicorandil , Rats , Rats, Wistar
11.
Naunyn Schmiedebergs Arch Pharmacol ; 349(2): 140-4, 1994 Feb.
Article in English | MEDLINE | ID: mdl-7513381

ABSTRACT

To compare in vivo effects of eleven compounds of different classes of histamine H1-receptor antagonists (alcoholamines: diphenhydramine, carbinoxamine, and clemastine; ethylenediamines: mepyramine, tripelennamine, and clemizole; alkylamines: triprolidine and chlorpheniramine; piperazines: meclizine and homochlorcyclizine; phenothiazines: promethazine) on neuronal uptake of dopamine (DA), noradrenaline (NA), and 5-hydroxytryptamine (5-HT), the effects on the turnover of these monoamines were examined in the mouse brain, based on the alpha-methyl-p-tyrosine-induced depletion of DA and NA or probenecid-induced accumulation of 5-hydroxyindoleacetic acid. The DA turnover was reduced remarkably by diphenhydramine, tripelennamine, and promethazine, and also significantly by chlorpheniramine, mepyramine, clemizole, and homochlorcyclizine, at doses used in the ordinary animal experiments. The 5-HT turnover was reduced markedly by mepyramine, tripelennamine, and chlorpheniramine. In contrast, the NA turnover was increased by promethazine and homochlorcyclizine, possibly due to their antagonistic effects on alpha-adrenoceptors. These results suggest that (1) the degree of inhibition of the uptake of DA and 5-HT by histamine H1-receptor antagonists is considerably different, (2) most H1-antagonists have little influence on NA uptake and some compounds enhance NA release, and that (3) carbinoxamine, clemastine, triprolidine, and meclizine have comparatively weak influences on monoamine metabolism. These effects on brain monoamine systems may be related to some central actions of histamine H1-receptor antagonists, such as an addiction to these compounds combined with opioids.


Subject(s)
Biogenic Monoamines/metabolism , Brain Chemistry/drug effects , Histamine H1 Antagonists/pharmacology , Animals , Dopamine/metabolism , Hydroxyindoleacetic Acid/metabolism , Male , Methyltyrosines/pharmacology , Mice , Mice, Inbred Strains , Norepinephrine/metabolism , Probenecid/pharmacology , Tyrosine 3-Monooxygenase/antagonists & inhibitors , alpha-Methyltyrosine
12.
Life Sci ; 48(21): 2065-73, 1991.
Article in English | MEDLINE | ID: mdl-1827856

ABSTRACT

The influence of footshock stress on the pharmacokinetics of nicorandil was examined in rats. In the group exposed to a 30-min period of footshock immediately after the oral administration of nicorandil (10 mg/kg), plasma nicorandil levels were markedly lower than those in the control group 30-120 min after administration. Plasma levels after the subcutaneous injection of nicorandil (5 mg/kg) were also slightly but significantly lower in stressed rats than in control rats. When footshock was applied from 60 min after oral administration or 30 min after subcutaneous injection (the time when the plasma nicorandil level was maximum), it also significantly decreased the plasma levels thereafter. Furthermore, footshock applied immediately after intravenous injection of nicorandil (3 mg/kg) significantly decreased the plasma levels 30-60 min after injection. Plasma levels of N-(2-hydroxyethyl) nicotinamide, one of the main metabolites of nicorandil, were slightly increased 30 min after the intravenous injection of nicorandil (10 mg/kg) by footshock. Nicorandil levels in the heart, kidney, and skin were significantly lower in the stressed rats similar to the change in the plasma level, but levels in the muscle, liver, and thymus showed no significant difference. The urinary excretion of nicorandil tended to be higher in the stressed rats. These results suggest that footshock stress affects not only the absorption of nicorandil but also its distribution, metabolism, and excretion.


Subject(s)
Niacinamide/analogs & derivatives , Stress, Physiological/metabolism , Vasodilator Agents/pharmacokinetics , Absorption , Administration, Oral , Animals , Electroshock , Injections, Intravenous , Injections, Subcutaneous , Male , Niacinamide/pharmacokinetics , Nicorandil , Rats , Rats, Inbred Strains , Stress, Physiological/blood , Stress, Physiological/urine , Tissue Distribution
14.
Pharmacology ; 38(6): 388-96, 1989.
Article in English | MEDLINE | ID: mdl-2530593

ABSTRACT

Influences of emotional stress on nicorandil pharmacokinetics were studied in rats that received physical and psychological stimuli (referred to as 'sender' and 'responder' rats, respectively) using the communication box paradigm. Concerning pharmacokinetic, there was no marked difference in the Tmax, Ka, Kel, T1/2 and Vd between the sender rats and the nonstressed control rats when both of which were orally administered 10 mg/kg of nicorandil. But the Cmax and AUC were lower and clearance (Cl) was higher in the sender rats. In the responder rats, there was no difference in Tmax, Ka, Kel, and T1/2. But the Cmax and AUC were lower and the Vd was higher than those of the control rats. On the other hand, when nicorandil was administered in a dose of 5 mg/kg subcutaneously, Tmax and T1/2 in the sender rats did not differ from those of the controls, but the Cmax, Ka and AUC were lower, and the Kel, Vd and Cl were higher. Between the responder and control rats, significant differences were found in all parameters except for Vd, i.e., Cmax, Ka, T1/2 and AUC were lower than those of control rats, and the Tmax, Kel and Cl were higher than those of control rats. This indicates that pharmacokinetics of nicorandil when administered orally and subcutaneously were influenced not only by physical stress but also by psychological stress.


Subject(s)
Animal Communication , Emotions/physiology , Stress, Psychological/metabolism , Animals , Chromatography, High Pressure Liquid , Male , Niacinamide/blood , Niacinamide/pharmacokinetics , Nicorandil , Rats , Rats, Inbred Strains , Spectrophotometry, Ultraviolet
SELECTION OF CITATIONS
SEARCH DETAIL
...